Kennedy D H, Fallon R J
JAMA. 1979 Jan 19;241(3):264-8.
To evaluate modern treatment and identify important factors influencing the outcome of tuberculous meningitis, clinical and laboratory findings in 52 patients aged from 9 months to 68 years have been reviewed. Patients were classified by clinical criterions at admission and at the start of treatment. Delay in commencing treatment was associated with deterioration and consequently poorer prognosis, but some severely ill patients made a good recovery. Forty-four survivors (85%) recovered, and only two patients (4%) had severe residual disability; eight (15%) of the patients died. Treatment should commence as soon as possible on clinical grounds without necessarily waiting for demonstration of Mycobacterium tuberculosis, as the organism can often be demonstrated in CSF withdrawn after the start of drug therapy.
为评估现代治疗方法并确定影响结核性脑膜炎预后的重要因素,我们回顾了52例年龄从9个月至68岁患者的临床和实验室检查结果。患者在入院时和治疗开始时依据临床标准进行分类。治疗开始延迟与病情恶化及预后较差相关,但一些重症患者恢复良好。44名幸存者(85%)康复,仅有2例患者(4%)有严重的残留残疾;8例患者(15%)死亡。应基于临床情况尽快开始治疗,不必等待结核分枝杆菌的证实,因为在开始药物治疗后从脑脊液中常可检出该病原体。